Anti-Lyn 抗体 [LYN-01]
Anti-Lyn antibody [LYN-01]
3
(6 Reviews)
|
(22 Publications)
Mouse Monoclonal LYN antibody. Suitable for Flow Cyt, WB and reacts with Human, Rat, Recombinant full length protein - Human samples. Cited in 22 publications. Immunogen corresponding to Recombinant Fragment Protein within Human LYN aa 1-250.
別名を表示する
JTK8, Tyrosine-protein kinase Lyn, Lck/Yes-related novel protein tyrosine kinase, V-yes-1 Yamaguchi sarcoma viral related oncogene homolog, p53Lyn, p56Lyn
- Flow Cyt
Unknown
Flow Cytometry - Anti-Lyn antibody [LYN-01] (AB1890)
Overlay histogram showing Ramos (Human Burkitt's lymphoma cell line) cells stained with ab1890 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab1890, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in Ramos cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
- WB
Supplier Data
Western blot - Anti-Lyn antibody [LYN-01] (AB1890)
Non reducing conditions with 60 minutes exposure time in a 12% gel
All lanes:
Western blot - Anti-Lyn antibody [LYN-01] (ab1890) at 1 µg/mL
Lane 1:
Negative control
Lane 2:
Rat basophilic leukemia cell line
Lane 3:
JURKAT human peripheral blood T cell leukemia cell line
Lane 4:
A-431 human epidermoid carcinoma cell line
Lane 5:
U-937 human histiocytic lymphoma cell line
Predicted band size: 59 kDa
false
- WB
AbReview20797****
Western blot - Anti-Lyn antibody [LYN-01] (AB1890)
All lanes:
Western blot - Anti-Lyn antibody [LYN-01] (ab1890) at 1/1000 dilution
All lanes:
HEK-293 (Human epithelial cell line from embryonic kidney) whole cell lysate at 50 µg
Secondary
All lanes:
HRP-conjugated anti-mouse at 1/10000 dilution
Predicted band size: 59 kDa
Observed band size: 56 kDa
false
Image courtesy of an anonymous Abreview.
- WB
Unknown
Western blot - Anti-Lyn antibody [LYN-01] (AB1890)
All lanes:
Western blot - Anti-Lyn antibody [LYN-01] (ab1890) at 1/1000 dilution
All lanes:
Recombinant human Lyn protein (ab60306) at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/3000 dilution
Predicted band size: 59 kDa
true
Exposure time: 4min
Reactivity data
製品の詳細
出荷温度及び保存条件
製品の状態
精製方法
精製に関する特記事項
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
As a regulator in signal transduction Lyn kinase is involved in the formation of protein complexes that modulate cell activation and proliferation. It participates in the phosphorylation of downstream substrates which leads to the initiation of various cellular responses. Lyn modulates pathways involving inflammation and immune responses impacting the development and function of immune cells. It is important for balancing activation and inhibition signals in the immune system ensuring a controlled immune response.
Pathways
Lyn kinase interacts with the B-cell receptor (BCR) signaling pathway and the Fc epsilon RI signaling pathway in mast cells. It associates with other Src family kinases like Fyn and Lck to regulate BCR signaling which influences B-cell development and differentiation. Lyn also acts upstream of pathways that control the release of inflammatory mediators. Through its role in these pathways Lyn indirectly impacts downstream processes and affects cellular communication and immune system homeostasis.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (22)
Recent publications for all applications. Explore the full list and refine your search
Disease models & mechanisms 17: PubMed38149669
2024
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 8:eabj5227 PubMed35452291
2022
Applications
Unspecified application
Species
Unspecified reactive species
Current oncology (Toronto, Ont.) 29:1939-1946 PubMed35323358
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular neuroscience 14:688050 PubMed34630032
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:662763 PubMed34485271
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 46:1409-1422 PubMed32945349
2020
Applications
Unspecified application
Species
Unspecified reactive species
eLife 8: PubMed31282857
2019
Applications
Unspecified application
Species
Unspecified reactive species
Biochimica et biophysica acta. Molecular cell research 1866:1498-1507 PubMed31255720
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 25:3674-3692.e10 PubMed30590041
2018
Applications
Unspecified application
Species
Unspecified reactive species
Biochimica et biophysica acta. Molecular basis of 1865:547-557 PubMed30579930
2018
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com